Synthesis and properties of a naproxen polymeric prodrug
- 1 August 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 54 (8) , 1129-1135
- https://doi.org/10.1211/002235702320266307
Abstract
A water-soluble polymeric prodrug containing a naproxen moiety was synthesized. The carboxylic groups of naproxen were condensed with the hydroxyl groups of 2-hydroxyethyl methacrylate (HEMA) to produce a drug-linked monomer, denoted HN. The polymeric prodrug was prepared by copolymerization of HN with methacrylic acid. The molar percentage of HN in the polymeric prodrug was 26 mol%, as determined by 1H NMR. To investigate the pertinence of this polymeric prodrug, the hydrolysis was studied in-vitro with or without esterase or lipase. The kinetics of enzymatic catalysis was calculated from a Lineweaver-Burk plot. The anti-inflammatory activity was evaluated using the carrageenan-induced oedema test. The polymeric prodrug released a major fraction of the free naproxen and a significant fraction of the hydroxyethyl ester derived-naproxen. The maximum hydrolysis rate Vmax, and the Michaelis constant Km were calculated to be 2.16 times 10−5 equiv. mol L−1 min−1 and 5.11 times 10−2 equiv. mol L−1. The maximum anti-inflammatory inhibition of free naproxen appeared at 2 h and quickly decreased thereafter. In contrast, the polymeric prodrug showed a maximum at around 2∼3 h and then slowly decreased. This indicates that the polymeric prodrug displays greater potency than free naproxen in the inhibition of acute inflammatory processes over long periods.Keywords
This publication has 11 references indexed in Scilit:
- In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenacEuropean Journal of Pharmaceutical Sciences, 2001
- Oral versus Topical NSAIDs in Rheumatic DiseasesDrugs, 2000
- Cyclic amide derivatives as potential prodrugs II: N-hydroxymethylsuccinimide- / isatin esters of some NSAIDs as prodrugs with an improved therapeutic indexEuropean Journal of Medicinal Chemistry, 1999
- Gastric Toxicity of Antiplatelet Therapy with Low-Dose AspirinDrugs, 1997
- Targetting of naproxen as naproxen-albumin conjugates to the liver: Protective effects against endotoxin intoxication in the rat in vivoEuropean Journal of Pharmaceutical Sciences, 1996
- Ester des Naproxens als potentielle Prodrugs zur Hautpenetration, 1. Mitt.: Synthese und physikochemische EigenschaftenArchiv der Pharmazie, 1994
- Macromolecular prodrugs. XIV. Absorption characteristics of naproxen after oral administration of a dextran T-70-naproxen ester prodrug in pigsInternational Journal of Pharmaceutics, 1989
- Macromolecular prodrugs. XII. Kinetics of release of naproxen from various polysaccharide ester prodrugs in neutral and alkaline solutionInternational Journal of Pharmaceutics, 1989
- Macromolecular Prodrugs. XVI. Colon-Targeted Delivery—Comparison of the Rate of Release of Naproxen from Dextran Ester Prodrugs in Homogenates of Various Segments of the Pig Gastrointestinal (GI) TractPharmaceutical Research, 1989
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934